Neutropenia in childhood: a 5-year experience at a tertiary center

Henric Lindqvist1, Göran Carlsson, Jacob Moell

  • 1Division of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, SE-141 86, Stockholm, Sweden, henke205@gmail.com.

Insights

Pediatric neutropenia, excluding congenital forms, generally follows a benign course. Most children with neutropenia do not require antibiotic prophylaxis or extensive medical care.

Area of Science:

  • Pediatrics
  • Hematology
  • Immunology

Background:

  • Clinical characteristics and laboratory findings are crucial for diagnosing childhood neutropenia and predicting healthcare needs.
  • Understanding the diverse etiologies and clinical presentations of neutropenia in children is essential for appropriate management.

Purpose of the Study:

  • To retrospectively investigate the presentation, laboratory findings, and intervention requirements in various types of pediatric neutropenia.
  • To analyze the clinical course and healthcare utilization patterns of children with different forms of neutropenia.

Main Methods:

  • Retrospective analysis of pediatric neutropenia cases followed at a single center between 2007 and 2012.
  • Comparison of clinical characteristics, absolute neutrophil granulocyte counts, duration of neutropenia, infection rates, and healthcare utilization across different neutropenia subtypes.

Main Results:

  • Children with congenital and autoimmune neutropenia presented younger with lower neutrophil counts (p < 0.01-0.05).
  • Remission duration was shorter for post-infection and drug-induced neutropenia compared to autoimmune and chronic idiopathic types (p = 0.001).
  • Ethnic and post-infection neutropenias were associated with fewer infections (p = 0.01-0.05); most neutropenic children had minimal infections and hospitalizations, with rare antibiotic prophylaxis use.

Conclusions:

  • Pediatric neutropenia, excluding congenital forms, typically exhibits a benign clinical course.
  • The majority of neutropenic children do not necessitate antibiotic prophylaxis or intensive medical management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
518
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
944